News

Vigiun was previously established by Eduardo Forleo and Elisa Halker. Dr Forleo has been appointed Chiltern’s country manager for Brazil and medical director for Latin America. Ms Halker

Oxycodone is reportedly the first product to be manufactured at Actavis’s Little Falls, New Jersey facility following a recently completed FDA inspection. In December 2008, Actavis has reached

This alliance will enable Siro to expand its oncology clinical development and patient recruitment expertise to North America. Advanced Clinical Trial (ACT) Solutions and its clients will benefit

Impact Fusion International holds worldwide patented technology on a health and wellness brand called Intact Natural Nutrition and its NutraMastic minerals. The shareholders of the company have also

Pursuant to the terms of the agreement, referring physicians of Zwanger-Pesiri will now be able to access images and reports through the MedLink EHR and MedLink EHR Lite.

According to Mersana, the studies showed that XMT-1107, a novel anti-angiogenic fumagillin analog conjugated to Mersana’s Fleximer, demonstrated superior anti-tumor activity in tumor xenograft models in comparison to

According to HST, this acquisition will allow the company to provide alternative healthcare options for those who are suffering from late stage cancer. Ron Howell, president and CEO

On April 17, 2009, CV Therapeutics merged with a wholly-owned subsidiary of Gilead. As a result of the merger, each outstanding share of CV Therapeutics not owned by

The new name reflects a major repositioning of the company to focus development activities on its drug candidate MIS416, which has shown promising activity in preclinical proof-of-principle studies